Combination%20Therapy
Showing 9976 - 10000 of >10,000
Surgery Trial in Boston (Conventional Free Gingival Graft Approach (FGG), Buccal Strip Graft with a collagen matrix (bSG + CM))
Recruiting
- Surgery
- Conventional Free Gingival Graft Approach (FGG)
- Buccal Strip Graft with a collagen matrix (bSG + CM)
-
Boston, MassachusettsHarvard School of Dental Medicine
Apr 25, 2023
Leg Ulcer Trial in Praha (Sevoflurane, Cyteal)
Recruiting
- Leg Ulcer
- Sevoflurane
- Cyteal
-
Praha, CzechiaFaculty Hospital Kralovske Vinohrady
May 19, 2022
Immune Checkpoint Inhibitors and Chemotherapy for Advanced
Completed
- Esophageal Cancer
-
Guangzhou, Guangdong, China
- +1 more
Mar 15, 2022
Teach-Back Communication Trial in Kocaeli (Trained by teaching back method, Management training)
Active, not recruiting
- Teach-Back Communication
- Trained by teaching back method
- Management training
-
Kocaeli, TurkeyOzel Anadolu Sağlik Merkezi
Apr 21, 2023
COVID-19 Trial in United States (Lopinavir/Ritonavir 400 mg/100 mg, Placebo)
Active, not recruiting
- COVID-19
- Lopinavir/Ritonavir 400 mg/100 mg
- Placebo
-
Aurora, Colorado
- +5 more
Aug 17, 2022
Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Trial in Vancouver (Cyclophosphamide,
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Cyclophosphamide
- +14 more
-
Vancouver, British Columbia, CanadaBC Cancer Agency
Jul 20, 2021
Cancer of the Breast Trial in United States (Omeprazole)
Completed
- Cancer of the Breast
-
Washington, District of Columbia
- +8 more
Dec 13, 2021
Plasmodium Falciparum Infection Trial in Worldwide (Artefenomel (OZ439), Ferroquine (SSR97193))
Completed
- Plasmodium Falciparum Infection
- Artefenomel (OZ439)
- Ferroquine (SSR97193)
-
Cotonou, Benin
- +6 more
Mar 10, 2022
Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)
Not yet recruiting
- Carcinoma, Hepatocellular
- Atezolizumab
- +3 more
- (no location specified)
Jun 14, 2023
Hypertension, Hyperlipidemia Trial in Worldwide (Amlodipine/atorvastatin single pill)
Completed
- Hypertension
- Hyperlipidemia
- Amlodipine/atorvastatin single pill
-
Buenos Aires, Argentina
- +117 more
Jan 26, 2021
Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)
Completed
- Neuroblastoma
- Medulloblastoma
- Nifurtimox
- +2 more
-
San Diego, California
- +14 more
Dec 28, 2022
Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer Trial in Worldwide (IV ICT01)
Recruiting
- Solid Tumor, Adult
- Hematopoietic/Lymphoid Cancer
- IV ICT01
-
New Haven, Connecticut
- +6 more
Oct 5, 2022
Renal Cell Carcinoma Trial in United States (Nivolumab, Ipilimumab)
Completed
- Renal Cell Carcinoma
-
Muscle Shoals, Alabama
- +60 more
Oct 6, 2022
Life Quality, Hospital Mortality Trial (high protein, rehabilitation, standard protein)
Not yet recruiting
- Life Quality
- Hospital Mortality
- high protein
- +2 more
- (no location specified)
Mar 24, 2023
Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)
Not yet recruiting
- Graft Vs Host Disease
- +5 more
- CliniMACS® device
- (no location specified)
Jul 20, 2023
Chronic Prostatitis/Chronic Pelvic Pain Syndrome With Erectile Dysfunction Trial in Guangzhou (Western Medicine Section
Completed
- Chronic Prostatitis/Chronic Pelvic Pain Syndrome With Erectile Dysfunction
- Western Medicine Section (Sildenafil)
- +2 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Sep 26, 2023
Head and Neck Tumors Trial in France (Atezolizumab, Bevacizumab)
Active, not recruiting
- Head and Neck Neoplasms
-
Lyon, France
- +6 more
May 16, 2022
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Houston (Rituximab, Zanubrutinib)
Recruiting
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Rituximab
- Zanubrutinib
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Recurrent Glioblastoma Trial (Sintilimab plus Bevacizumab and Temozolomide)
Not yet recruiting
- Recurrent Glioblastoma
- Sintilimab plus Bevacizumab and Temozolomide
- (no location specified)
Nov 27, 2022
Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)
Not yet recruiting
- Advanced Breast Cancer
-
Seoul, Korea, Republic ofSeoul National University Hospital
Sep 12, 2022
Brain Metastases From NSCLC Trial (Stereotactic Radiation Therapy, Durvalumab)
Not yet recruiting
- Brain Metastases From Non-small Cell Lung Cancer
- Stereotactic Radiation Therapy
- Durvalumab
- (no location specified)
May 24, 2022
Metastatic Breast Cancer With a Isolated Brain Progression Trial in France (Tucatinib, Pertuzumab, Trastuzumab)
Recruiting
- Metastatic Breast Cancer With a Isolated Brain Progression
- Tucatinib
- +4 more
-
Angers, France
- +33 more
Aug 10, 2022
Muscle Pain, Feedback, Psychological, Craniomandibular Disorders Trial in Wroclaw (Electromyography Biofeedback, Classic
Not yet recruiting
- Muscle Pain
- +4 more
- Electromyography Biofeedback
- Classic treatment for myogenous TMD
-
Wrocław, Dolny Śląsk, PolandWroclaw Medical University
Jul 5, 2021
Ovarian Cancer Trial in Shanghai (chiauranib, etoposide, paclitaxel)
Completed
- Ovarian Cancer
- chiauranib
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 17, 2021
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +19 more
- Proton Beam Radiation Therapy
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2023